Waverton UK B GBPRegister to Unlock Ratings |
Performance History | 31/05/2016 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.2 | 26.8 | 0.2 | 5.3 | -1.6 | |
+/-Cat | -6.3 | 3.3 | -0.8 | 2.9 | - | |
+/-B’mrk | - | - | - | - | - | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 16/06/2016 | GBP 12.25 | |
Day Change | -0.72% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | IE00B1RMZN38 | |
Fund Size (Mil) 21/11/2024 | GBP 15.32 | |
Share Class Size (Mil) 16/06/2016 | GBP 0.05 | |
Max Initial Charge | - | |
Ongoing Charge 16/04/2024 | 0.80% |
Investment Objective: Waverton UK B GBP |
The investment objective of the Fund is to achieve long-term capital growth and income through diversified investment in UK equities. Not less than two thirds of the total assets (without taking into account Ancillary Liquid Assets) will be invested in securities of issuers domiciled in the UK and which are quoted on markets established in the UK. Up to one third of the total assets of the Fund (without taking into account Ancillary Liquid Assets) may be invested in securities of issuers carrying out business in the UK or which are quoted on other markets. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Tineke Frikkee 01/08/2018 | ||
Inception Date 30/03/2007 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI UK All Cap NR USD | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Waverton UK B GBP | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 8.60 |
Shell PLC | Energy | 8.29 |
London Stock Exchange Group PLC | Financial Services | 5.65 |
National Grid PLC | Utilities | 5.50 |
Barclays PLC | Financial Services | 4.48 |
Increase Decrease New since last portfolio | ||
Waverton UK B GBP |